Despite entering its maturation phase, the recombinant protein sector will continue to drive the growth of medical biotechnology over the next six years. You have full access to this article via ...

Recombinant Proteins market in terms of revenue was estimated to be worth $2.2 billion in 2023 and is poised to reach $3.2 ...

tebu-bio offers recombinant protein production services using a robust, inexpensive and fast transient-expression system in Chinese hamster ovary (CHO) cells, for various research and development ...

The Recombinant Protein Production and Characterization (RPPC) Core is an Institutional Advanced Technology Core available to all Baylor College of Medicine investigators on a fee-for-service basis.

The Global Antibody and Recombinant Protein Contract Development and Manufacturing Organization (CDMO) Market is witnessing remarkable growth, driven by the increasing demand for biologics and ...

To maintain vaccine efficacy, WHO regularly updates influenza vaccine strains based on global epidemiological, virological, ...

Although plant cell-based bioproduction has advanced considerably during the past several years, certain elements remain largely unexplored.

With streamlined processes tailored to accommodate a diverse range of project requirements from research through commercial manufacturing, the EffiX™ platform accelerates the advancement of innovative ...